SMALL CELL CARCINOMA OF LUNG
Clinical trials for SMALL CELL CARCINOMA OF LUNG explained in plain language.
Never miss a new study
Get alerted when new SMALL CELL CARCINOMA OF LUNG trials appear
Sign up with your email to follow new studies for SMALL CELL CARCINOMA OF LUNG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for lung cancer that morphs after treatment: combo therapy targets transformed cells
Disease control Recruiting nowThis study tests a new drug combination for people whose lung cancer has changed from one type to another (from adenocarcinoma to small cell lung cancer) after initial treatment. About 50 adults will receive tarlatamab plus standard chemotherapy and immunotherapy. The goal is to …
Matched conditions: SMALL CELL CARCINOMA OF LUNG
Phase: PHASE2 • Sponsor: Se-Hoon Lee • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New drug targets tumors directly in early trial
Disease control Recruiting nowThis early-phase trial tests a new drug called AVA6103 in about 144 people with advanced solid tumors (like pancreatic, stomach, or lung cancer) that have not responded to standard treatments. The drug is designed to activate only inside tumors to kill cancer cells while limiting…
Matched conditions: SMALL CELL CARCINOMA OF LUNG
Phase: PHASE1 • Sponsor: Avacta Life Sciences Ltd • Aim: Disease control
Last updated May 06, 2026 16:03 UTC
-
Lung cancer Patients' fitness tracked during therapy
Knowledge-focused Recruiting nowThis study looks at how lung cancer and its treatment affect patients' heart and lung fitness. About 90 adults with lung cancer will take a safe exercise test before and after starting standard therapy. The goal is to learn which patients may need extra monitoring, not to test a …
Matched conditions: SMALL CELL CARCINOMA OF LUNG
Sponsor: Medical University of Bialystok • Aim: Knowledge-focused
Last updated May 14, 2026 12:04 UTC